Skip to content
Search

Latest Stories

Johnson & Johnson is the world’s most innovative pharmaceutical company

Johnson & Johnson is the world’s most innovative pharmaceutical company

Johnson & Johnson spent £37.1 billion on intangible assets and £11.87 billion on R&D last year

Johnson & Johnson has made it to the list of top 10 most innovative companies in the world released by FOREX.com.


The US-based pharmaceutical company is the fourth most innovative company, scoring 8.23/10 in the innovation index.

Johnson & Johnson is the only pharmaceutical company making it to top 10 list, which makes it the world’s most innovative pharmaceutical company in 2023.

The ranking is based on many factors such as the number of US-registered patents in 2022, the number of R&D expenses over the last 12 consecutive months and their last reported intangible assets.

The health giant spent £37.16 billion on intangible assets (the second highest after Apple), £11.87 billion on R&D last year and registered 1,377 patents last year.

Consumer electronic companies dominated the list, securing the top three spots.

Samsung tops the list with an innovation score of 9.25/10 and the highest number of new patents in 2022 (8,513).

Matthew Weller, Head of Global Market Commentary at FOREX.com, said: “The report's findings underscore Samsung's dominance in the innovation arena, with its leading number of patents reflecting a significant push in consumer electronics. This patent portfolio is not just a measure of quantity but a marker of Samsung's potential to disrupt markets and set new industry standards.”

Despite having spent the most on intangible assets out of all companies, Apple slipped to second position in the list, scoring 9.03/10.

IT giant IBM is in the third place with a score of 8.33/10 and the second highest number of new patents registered in 2022 (4743).

Intel invested 31.6 per cent (£13.6 billion) of their £43 billion revenue - the most out of all companies.

E-commerce giant, Amazon, has invested the most in R&D in the last year (£65 billion).

Experts at FOREX.com have prepared the list by analysing data from Harrity and Seeking Alpha to uncover which companies are the most innovative.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less